Citadel Advisors
NYMX

Citadel Advisors’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Citadel Advisors’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-25,040
Closed -$4.76K – 15628
2023
Q2 		$4.76K Sell
25,040
-35,266
-58% -$13.9K ﹤0.01% 13570
2023
Q1 		$20.5K Sell
60,306
-23,858
-28% -$9.7K ﹤0.01% 13050
2022
Q4 		$25K Buy
+84,164
New +$30.5K ﹤0.01% 12944
2022
Q2 		– Sell
-12,240
Closed -$15K – 14581
2022
Q1 		$15K Buy
+12,240
New +$18.9K ﹤0.01% 13318
2020
Q3 		– Sell
-17,691
Closed -$63K – 10961
2020
Q2 		$63K Buy
+17,691
New +$56K ﹤0.01% 9207
2020
Q1 		– Sell
-28,706
Closed -$80.6K – 10381
2019
Q4 		$63K Buy
28,706
+15,743
+121% +$31.1K ﹤0.01% 8693
2019
Q3 		$24K Buy
+12,963
New +$22.7K ﹤0.01% 8899
2019
Q2 		– Sell
-23,544
Closed -$41.2K – 10055
2019
Q1 		$46K Buy
23,544
+4,386
+23% +$9.3K ﹤0.01% 8855
2018
Q4 		$25K Sell
19,158
-16,308
-46% -$29.9K ﹤0.01% 8680
2018
Q3 		$87K Sell
35,466
-18,259
-34% -$53.9K ﹤0.01% 8629
2018
Q2 		$181K Buy
53,725
+43,604
+431% +$168K ﹤0.01% 7968
2018
Q1 		$43K Buy
+10,121
New +$35.1K ﹤0.01% 7972
2017
Q4 		– Sell
-10,646
Closed -$38.8K – 8583
2017
Q3 		$41K Buy
+10,646
New +$40.4K ﹤0.01% 7226
2017
Q2 		– Sell
-34,163
Closed -$140K – 8245
2017
Q1 		$124K Buy
+34,163
New +$112K ﹤0.01% 6779
2016
Q4 		– Sell
-32,661
Closed -$101K – 8022
2016
Q3 		$106K Buy
+32,661
New +$107K ﹤0.01% 6635
2015
Q3 		– Sell
-23,076
Closed -$31K – 9336
2015
Q2 		$31K Sell
23,076
-8,999
-28% -$12.6K ﹤0.01% 7945
2015
Q1 		$27K Sell
32,075
-4,307
-12% -$2.03K ﹤0.01% 7743
2014
Q4 		$15K Buy
36,382
+31,893
+710% +$68K ﹤0.01% 7986
2014
Q3 		$20K Buy
+4,489
New +$22K ﹤0.01% 7432
2014
Q2 		– Sell
-39,506
Closed -$203K – 8404
2014
Q1 		$216K Buy
+39,506
New +$229K ﹤0.01% 5432

Other funds holding NYMX

DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
FCFC
First Citizens Financial Corp Mason City, Iowa $239M AUM 26.56% 1-Year Est. Return
CAM
Cubic Asset Management Boston, Massachusetts $422M AUM 29.18% 1-Year Est. Return
ODIJL
One Day In July LLC Burlington, Vermont $1.25B AUM 12.08% 1-Year Est. Return

Citadel Advisors's NYMX Position: Q3 2023 in Review

Citadel Advisors sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2023, closing a stake of 25,040 shares — an estimated $4.76K sold.

Citadel Advisors first reported a position in NYMX in Q1 2014 and held it in 20 quarters. The position peaked at $216K in Q1 2014. 5 funds tracked by Wall St. Rank hold NYMX as of Q3 2023.

  • Citadel Advisors reported no remaining Nymox Pharmaceutical Corp position as of Q3 2023 after selling out during the quarter.
  • Citadel Advisors sold 25,040 Nymox Pharmaceutical Corp shares in Q3 2023, an estimated $4.76K.
  • Citadel Advisors first reported a position in Nymox Pharmaceutical Corp in Q1 2014 and held it in 20 quarters.
  • Citadel Advisors's Nymox Pharmaceutical Corp position peaked at $216K in Q1 2014.
  • 5 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2023.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.